|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 31/137 | (2006.01) |
| A61P 25/08 | (2006.01) |
| (11) | Number of the document | 3329909 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18152406.7 |
| Date of filing the European patent application | 2014-05-01 | |
| (97) | Date of publication of the European application | 2018-06-06 |
| (45) | Date of publication and mention of the grant of the patent | 2021-03-17 |
| (46) | Date of publication of the claims translation | 2021-07-12 |
| (30) | Number | Date | Country code |
| 201313887014 | 2013-05-03 | US |
| (72) |
Ceulemans, Berten, BE
Lagae, Lieven, BE
|
| (73) |
Katholieke Universiteit Leuven KU Leuven Research & Development,
Waaistraat 6 Box 5105, 3000 Leuven,
BE
University Hospital Antwerp, Wilrijkstraat 10, 2650 Edegem, BE |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Fenfluraminas, skirtas naudoti Draveto sindromo gydymui |
| FENFLURAMINE FOR USE IN THE TREATMENT OF DRAVET SYNDROME |
| Payment date | Validity (years) | Amount | |
| 2024-04-05 | 11 | 289.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2024-10-01 |